SCHEMBL8166222

SCHEMBL8166222

C/C=C(\CCc1ccccc1)C(=O)O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.59
KEAP1 Q14145 1/20 0.57
FFAR1 O14842 2/20 0.53
HDAC2 Q92769 2/20 0.50
HDAC8 Q9BY41 2/20 0.50
HDAC6 Q9UBN7 2/20 0.50
TDP1 Q9NUW8 2/20 0.50
GPR52 Q9Y2T5 1/20 0.49
KMT2A Q03164 1/20 0.49
HDAC1 Q13547 2/20 0.48
HDAC3 O15379 1/20 0.48
MAPK1 P28482 1/20 0.48
ADRA1A P35348 1/20 0.48
HDAC4 P56524 1/20 0.48
SLC6A3 Q01959 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
HDAC7 Q8WUI4 1/20 0.48
HDAC10 Q969S8 1/20 0.48
HDAC11 Q96DB2 1/20 0.48
HDAC9 Q9UKV0 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9009723 1.00 ALDH1A1 (0.59) ALDH1A1KEAP1FFAR1HDAC2HDAC8
SCHEMBL4667864 0.89 HDAC1 (0.60) ALDH1A1KEAP1HDAC2HDAC8HDAC6
SCHEMBL10507164 0.83 ALDH1A1 (0.53) ALDH1A1KEAP1FFAR1HDAC2HDAC8
SCHEMBL2682990 0.82 KEAP1 (0.55) ALDH1A1KEAP1FFAR1HDAC2HDAC8
SCHEMBL10899478 0.82 KEAP1 (0.55) ALDH1A1KEAP1FFAR1HDAC2HDAC8
SCHEMBL166472 0.82 KEAP1 (0.55) ALDH1A1KEAP1FFAR1HDAC2HDAC8
SCHEMBL30136406 0.82 ALDH1A1 (0.47) ALDH1A1KEAP1FFAR1TDP1KMT2A
SCHEMBL23630344 0.82 ALDH1A1 (0.52) ALDH1A1KEAP1FFAR1HDAC2HDAC8
SCHEMBL6451798 0.82 ALDH1A1 (0.52) ALDH1A1KEAP1FFAR1HDAC2HDAC8
SCHEMBL9619650 0.82 ALDH1A1 (0.52) ALDH1A1KEAP1FFAR1HDAC2HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018145219-A1 PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING ADDICTIONS BY MEANS OF AVERSIVE COUNTERCONDITIONING SERANI MOSTAZAL JORGE (CL) 2018-08-16 WO claimed
US-6048852-A BACTERICIDES SMITHKLINE BEECHAM P.L.C. (GB) 2000-04-11 US disclosed